Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein

Abbas, W; Khan, K A; Kumar, A; Tripathy, M K; Dichamp, I; Keita, M; Mahlknecht, U; Rohr, O; Herbein, G

doi:10.1038/cddis.2014.16

Download PDF

Original Article
Open access
Published: 20 February 2014

Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein

W Abbas¹,
K A Khan¹,
A Kumar ORCID: orcid.org/0000-0002-7398-0498¹,
M K Tripathy¹,
I Dichamp¹,
M Keita¹,
U Mahlknecht²,
O Rohr³ &
…
G Herbein¹

Cell Death & Disease volume 5, page e1080 (2014)Cite this article

1916 Accesses
16 Citations
Metrics details

Subjects

Abstract

HIV-1 Nef protein has key roles at almost all stages of the viral life cycle. We assessed the role of Nef and of the translation elongation factor eEF1A in primary human macrophages. Nuclear retention experiments and inhibition of the exportin-t (Exp-t) pathway suggested that cytoplasmic relocalization of eEF1A, mediated by Exp-t occurs in Nef-treated monocyte-derived macrophages (MDMs). We observed the presence of tRNA in the Nef/eEF1A complexes. Nucleocytoplasmic relocalization of the Nef/eEF1A complexes prevented stress-induced apoptosis of MDMs treated with brefeldin A. Blockade of stress-induced apoptosis of MDMs treated with HIV-1 Nef resulted from enhanced nucleocytoplasmic transport of eEF1A with decreased release of mitochondrial cytochrome c, and from increased tRNA binding to cytochrome c, ultimately leading to an inhibition of caspase activation. Our results indicate that HIV-1 Nef, through the nucleocytoplasmic relocalization of eEF1A and tRNAs, enhances resistance to stress-induced apoptosis in primary human macrophages.

Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice

Article Open access 25 April 2024

A guide to cell death pathways

Article 18 December 2023

Mechanisms of SARS-CoV-2 entry into cells

Article 05 October 2021

Main

The endoplasmic reticulum (ER) is a well-orchestrated protein-folding machine composed of protein chaperones, proteins that catalyze protein folding, and sensors that detect the presence of misfolded or unfolded proteins. The unfolded protein response (UPR) is an intracellular signaling pathway that coordinates the ER protein-folding demand with protein-folding capacity and is essential to adapt to homeostatic alterations that cause protein misfolding.¹ Accumulating evidence suggests that protein folding and generation of reactive oxygen species (ROS) as a byproduct of protein oxidation in the ER are closely linked events. It has also become apparent that activation of the UPR on exposure to oxidative stress is an adaptive mechanism to preserve cell function and survival.¹ Persistent oxidative stress and protein misfolding initiate apoptotic cascades and are now known to have predominant roles in the pathogenesis of multiple human diseases including diabetes, atherosclerosis, and neurodegenerative diseases.²

Activated monocytes are a major source of ROS that are essential for bacterial killing.³ However, excessive ROS production not appropriately compensated by antioxidant molecules can lead to oxidative stress, which may also have an important role in pathogenesis of HIV infection through various mechanisms.⁴ ROS participate in T-lymphocyte depletion by triggering apoptosis; and monocytes can also induce their own apoptosis by producing ROS.⁵ HIV infection leads to the production of ROS in infected cells and causes transient downregulation of the antiapoptotic Bcl-2 and thioredoxin (TRX) protein expression in Jurkat and U937 cells, followed by restoration to initial levels. Cells with decreased levels of these proteins are susceptible to apoptosis.⁴ In addition, the upregulation of Bcl-2 expression represses HIV replication; therefore, the state of low level viral replication may be favorable for cell survival, resulting in persistent infection.⁶ In monocytes, from asymptomatic patients, the levels of Bcl-2 and TRX decrease, which is associated with enhanced hydrogen peroxide production, whereas in cells from AIDS patients the levels returned to normal.⁶ Thus, the redox balance affected by the intracellular TRX system seems to be important for cell survival and low viral production, probably leading to chronic persistent infection of HIV. HIV-1Tat has been reported to induce UPR,⁷ indicating that ER stress response could be a critical parameter to control during HIV infection.

Nuclear–cytoplasmic transport of all molecules, such as proteins and RNA species, across the nuclear envelope occur through the channels formed by macromolecular structures known as nuclear pore complexes. The translation elongation factor EF1A has been described as a cytoplasmic component of the nuclear aminoacylation-dependent tRNA export pathway.⁸ eEF1A interacts directly with aminoacylated tRNAs. Exp-t has been reported to have a major role in eEF1A-mediated export, though Exp-5, which preferentially exports pre-miRNAs, has been reported to be involved in the nuclear–cytoplasmic transport of tRNAs in some cases.⁹ In addition to the conventional role of eEF1A during protein synthesis, namely GTP-dependent binding and transport of aminoacyl-tRNA to the A site of the ribosome, eEF1A has a role in the cytoplasm. One of the proposed unconventional functions of eEF1A is a role in the regulation of cytoskeletal dynamics.¹⁰ In addition to binding GDP/GTP, aminoacyl-tRNA, EF1β, and the ribosome, eEF1A binds and bundles actin and binds microtubules. Because eEF1A is an abundant protein in most eukaryotic cells and binds to actin filaments with relatively high affinity, it could be a potent regulator of the cytoskeleton.¹¹ Previous in vitro studies demonstrated that eEF1A inhibits the rate of actin polymerization and stabilizes actin filaments.¹²

In addition, eEF1A has been reported to have a role in apoptosis or programmed cell death. Early experiments showed that the level of eEF1A expression in cultured mouse fibroblasts correlates with the rate of apoptosis on serum withdrawal, with higher levels of eEF1A expression associated with a faster rate of cell death.¹³ Other studies have indicated that eEF1A prevents cell death; and numerous studies have shown that eEF1A expression increases in tumor cells and tumor tissues parallel with decreased caspase-3 activation.^{14, 15}

Nef, a 27-kDa HIV-1 protein, is translated from multiply spliced viral mRNAs early during infection.¹⁶ Endogenous Nef may have evolved a number of different, independent functional activities to enhance the replication and survival of the virus within infected cells and to facilitate its spread in vivo.¹⁷ Nef enhances virion infectivity and increases viral replication in primary lymphocytes and macrophages.¹⁸ The protein can also mediate downregulation of CD4 cell surface expression, a phenomenon important for the release of HIV-1 from the infected cell.¹⁷ In addition, Nef can downregulate the cell surface expression of major histocompatibility complex class I (MHC-I) molecules, an effect found to protect infected cells from cytotoxic T cells.¹⁹ The Nef protein prevents apoptosis of HIV-1-infected T cells through either interference with Fas/TNFα receptor death-signaling pathways by inhibiting apoptosis signal-regulating kinase 1 (ASK-1)²⁰ or the formation of a complex with both p21-activated kinase (PAK) and phosphatidylinositol-3 kinase (PI3K), which increases phosphorylation and inactivation of the pro-apoptotic Bad protein.²¹ HIV-1 Nef protects human monocyte-derived macrophages (MDMs) from HIV-1-induced apoptosis, and this protection correlates with the hyperphosphorylation and consequent inactivation of Bad.²² Nef expression within macrophages has been reported to favor the recruitment of resting T cells via the secretion of C–C chemokines and to subsequently favor their activation, suggesting a role for Nef in lymphocyte recruitment and activation at sites of viral replication.²³

Our results indicate that HIV-1 Nef associates with eEF1A and that Exp-t contributes to the nuclear–cytoplasmic transport of Nef/eEF1A/tRNA complexes in macrophages. Finally, we observed that cytoplasmic relocalization of the Nef/eEF1A/tRNA complexes prevents stress-induced apoptosis in macrophages via increased cytoplasmic eEF1A expression, decreased release of mitochondrial cytochrome c, and plugging of released cytochrome c by cytoplasmic tRNAs, ultimately resulting in decreased caspase activation.

Results

Interaction between HIV-1 Nef and eEF1A

As both Nef and eEF1A modulate apoptosis,^{14, 22} we assessed whether eEF1A is part of a eEF1A/Nef complex. To test this interaction, we expressed a Nef–GST fusion protein in E. coli and tested its ability to interact with eEF1A from U937 cell lysates. The Nef protein bound to eEF1A (Figure 1a). Endogenous eEF1A protein present in the lysates of Vero cells, MRC5 cells, promonocytic U937 cells, primary peripheral blood lymphocytes (PBLs), and primary MDMs co-immunoprecipitated with recombinant Nef (rNef) added to the culture, whereas the isotype control showed no associated eEF1A protein on immunoprecipitation (Figure 1b). The interaction between eEF1A and rNef was detected in both nuclear and cytoplasmic lysates prepared from the cells (Figure 1b).

The interaction between eEF1A and endogenous Nef was also demonstrated by transient transfection of U937 cells with a nef-expressing plasmid (Figure 1c), and in peripheral blood mononuclear cells (PBMCs) infected in vitro with HIV-189.6 (Figure 1d). Thus, eEF1A interacts with the Nef protein, not only in vitro within several cell types treated with rNef but also with the endogenous Nef protein produced within HIV-1-infected primary PBMCs. Lysates from MDMs treated with rNef in vitro were immunoprecipitated with antibodies directed against the eukaryotic translation elongation factor-2 (eEF2), and western blot performed with an anti-Nef antibody. The Nef protein did interact with eEF1A, but not with eEF2 (data not shown), indicating that the Nef/eEF1A interaction was specific. We further investigated the interaction between eEF1A and Nef using a mammalian two-hybrid assay. Nef fused to the GAL4 DNA-binding domain (pBIND) was used as the bait vector, and eEF1A fused to the VP16-activation domain (pACT) was used as the prey vector (Figure 1e). The constructs were transfected into mammalian cells along with the pG5-Luc vector, which contains five GAL4-binding sites upstream of a minimal TATA box upstream of the luciferase gene. The interaction between the GAL4-Nef and VP16-eEF1A fusion constructs resulted in an 18-fold increase of relative luciferase expression over the negative control (1847 versus 105 relative light units (r.l.u.); Figure 1f). Expression of pGAL4-Nef alone or pVP16- eEF1A alone did not result in increased luciferase activity compared with negative controls (115 r.l.u. and 103 r.l.u., respectively).

Determination of eEF1A and HIV-1 Nef regions involved in eEF1A–Nef interaction

To determine the region of eEF1A responsible for association with HIV-1 Nef, we used deletion mutants engineered within the cDNA encoding eEF1A.²⁴ Lysates from bacteria expressing N-terminal HA-tagged eEF1A mutants were used in binding reactions with GST-HIV-1 Nef. The deletion mutants we analyzed are shown in Figure 2a. Three of the deletion mutants were not stably expressed.²⁴ Of the deletion mutants that were expressed, only the eEF1A 1-74 mutant was capable of binding Nef (Figure 2a). These results demonstrate that the eEF1A fragment encoding the N-terminal 74 amino acids is sufficient for HIV-1 Nef binding. To determine the region of HIV-1 Nef responsible for binding to eEF1A, two GST-Nef deletion mutants (N-terminus, GST-Nef1-60; C-terminus, GST-Nef55-206) were produced and assayed for their ability to associate with eEF1A in vitro (Figure 2b). The GST-Nef1-60 and GST-Nef55-206 mutants had intact N-terminal and C-terminal sequences (data not shown). Lysates from MDMs were used in binding reactions with GST-HIV-1 Nef constructs. Of the three GST–Nef constructs, only GST-NefWT and GST-Nef55-206 were capable of binding eEF1A (Figure 2b). These results demonstrate that the N-terminus of Nef is not required for eEF1A binding, and that the Nef fragment encoding amino acids 55–206 is sufficient.

Cytoplasmic relocalization of eEF1A by HIV-1 Nef is mediated by Exp-t

The eEF1A protein is found in both the nucleus and cytoplasm of cells, which favors the nuclear export of mature tRNAs. In the absence of Nef, we observed relatively more eEF1A in the nucleus than the cytoplasm of primary MDMs (Figure 3a, mock). To determine whether Nef, via its interaction with eEF1A, interferes with the nuclear–cytoplasmic distribution of eEF1A, we treated MDMs with rNef.²⁵ Nuclear and cytoplasmic extracts were prepared from cells treated up to 12 h with rNef, and eEF1A, Exp-t and rNef were assessed in both cellular compartments. rNef enhanced the nuclear–cytoplasmic transport of eEF1A up to 12 h post treatment in MDMs (Figure 3a). Our results indicate that rNef could actively favor the nuclear export of eEF1A in MDMs.

We tested several exportins, Exp-t, Exp-1, and Exp-5, in regard to the nuclear–cytoplasmic transport of eEF1A in the presence of rNef. Using MDM lysates, we detected a direct interaction between GST-Nef and Exp-t using a pull-down assay (Figure 3b). No direct interaction between GST-Nef and Exp-1 was observed (data not shown). Using lysates from untreated MDMs, we detected an interaction between eEF1A and Exp-t by co-immunoprecipitation (Figure 3c). We did not detect any interaction between eEF1A and Exp-1 in untreated MDMs (data not shown). Confirming a potential interaction between Exp-t, eEF1A and Nef, we observed an increase in eEF1A and Exp-t in the cytoplasmic extracts from MDMs treated with rNef as early as 30 min post treatment (Figure 3a). A sustained presence of rNef and eEF1A was detected in the cytoplasm of rNef-treated MDMs up to 12 h post treatment (Figure 3a). To determine the role of Exp-t in the nuclear–cytoplasmic transport of rNef/eEF1A complexes, MDMs were transfected with Exp-t siRNA 48 h before treatment with rNef. Knockdown of the Exp-t protein in MDMs was monitored by western blot (Figure 3d). Knockdown of Exp-t resulted in enhanced nuclear retention of eEF1A and rNef in MDM cultures treated with rNef (Figure 3e). We did not detect any nuclear retention of rNef or eEF1A following treatment of MDMs with the Exp-1 inhibitor leptomycin B or Exp-5 siRNA (data not shown). Our results indicate that, in rNef-treated MDMs, the nuclear–cytoplasmic transport of rNef/eEF1A complexes is preferentially mediated by Exp-t.

Nuclear–cytoplasmic relocalization of eEF1A by rNef blocks stress-induced apoptosis in macrophages

Brefeldin A (BFA) disrupts the organization of the microtubule and actin cytoskeleton and exerts ER and Golgi stress, resulting in apoptosis (Supplementary Figure 1). Interestingly, eEF1A is an actin/microtubule-binding protein and could interfere with BFA-induced apoptosis. Therefore, we examined whether nuclear–cytoplasmic transport of eEF1A by rNef inhibits BFA-induced apoptosis in MDMs, potentially due to cytoplasmic accumulation of eEF1A. We observed that pretreatment with rNef inhibits BFA-induced apoptosis in MDMs in a dose-dependent manner (Figure 4a). In addition, pretreatment with rNef did not inhibit apoptosis induced by tunicamycin (TM) or thapsigargin (TG) that disturb protein glycosylation or Ca2+ signaling, respectively (Figure 4b). Of the three Nef proteins, only NefWT and Nef55-206 were capable of blocking BFA-induced apoptosis in MDMs (Figure 4c).

Because Exp-t is involved in nuclear–cytoplasmic transportation of the eEF1A/rNef complexes, we assessed apoptosis among MDMs treated with rNef before BFA treatment and transfected with siRNA Exp-t, siRNA Exp-1, siRNA Exp-5, or a scrambled control. We observed that transfection with siRNA Exp-t, but not siRNA Exp-1 or siRNA Exp-5, inhibited the rNef-mediated blockade of apoptosis in MDMs treated with BFA (Figure 4d). Furthermore, the knockdown of eEF1A by siRNA inhibited the Nef-mediated blockade of apoptosis in MDMs treated with BFA (Figure 4e). Our results indicate that Exp-t-mediated nuclear–cytoplasmic transport of the rNef/eEF1A complexes in MDMs is involved in the inhibition of apoptosis triggered by stress, such as BFA treatment.

As shown in Figure 5a, p35 pro-caspase-3 is diminished and cleaved to p20/p17 proteins in MDMs treated with BFA, confirming that BFA-induced apoptosis activates caspase-3.^{26, 27} Under ER stress treatments, such as BFA, the magnitude of protection against apoptosis directly correlates with the level of cytoplasmic eEF1A expression;^{28, 29} therefore, we measured the levels of eEF1A in the cytosol of BFA-stimulated MDMs treated with increasing concentrations of Nef. We observed that the levels of cytosolic eEF1A positively correlated with Nef treatment in a dose-dependent manner, as well as with the resistance to apoptosis in BFA-stimulated MDMs as measured by decreased caspase-3 activation and cytochrome c release (Figure 5b).

Cytoplasmic extracts of BFA-stimulated MDMs treated with rNef, in the absence or presence of Exp-t siRNA, Exp-1 siRNA, or Exp-5 siRNA, were analyzed for caspase-3 activation. Exp-t, Exp-1, and Exp-5 knockdown in MDMs was monitored by western blot (Figures 3d and 5c). Knockdown of Exp-t, but not Exp-1 or Exp-5, relieved the Nef-mediated blockade of apoptosis in BFA-stimulated MDMs (Figure 5d). Relief of the Nef-mediated blockade of apoptosis in BFA-stimulated MDMs transfected with Exp-t siRNA was accompanied by decreased cytoplasmic eEF1A (Figure 5d). Our results indicate a critical role for Exp-t and eEF1A in resistance to apoptosis in BFA-treated MDMs.

Cytochrome c-induced caspase-9 activation is regulated at multiple levels, and tRNA was reported recently to bind to cytochrome c, blocking formation of the apoptosome and the subsequent activation of caspase-9.³⁰ Therefore, we tested whether Nef can prevent cytochrome c release in the cytoplasm. We found that most of the cytochrome c was detected in the mitochondrial fraction from normal MDMs, whereas the majority of the cytochrome c in BFA-treated MDMs was detected in the cytosolic fraction (Figure 5e). In Nef-treated MDMs, most of the cytochrome c was detected in the mitochondrial fractions, even after BFA stimulation, which suggests that mitochondrial cytochrome c release is blocked by Nef treatment (Figure 5e).

As shown in Figure 5f, cleavage of 45-kDa procaspase-9 to a 35-kDa fragment in MDMs treated with BFA was blocked by Nef, but not by inactivated boiled Nef, confirming that BFA-induced apoptosis activates caspase-9 and that it can be inhibited by Nef. The processing of caspase-9 induced by BFA in Nef-treated MDMs was inhibited in a dose-dependent manner (Figure 5g), indicating that Nef may function by preventing the activation of caspase-9 via decreased release of mitochondrial cytochrome c. As shown in Figure 5h, pretreatment with rNef did not inhibit the processing of caspase-3 and caspase-9 induced by TM or TG.

eEF1A/Nef complexes contain tRNAs and block stress-induced apoptosis in MDMs through tRNA binding to cytochrome c

As both eEF1A and HIV-1 Nef bind to tRNAs preferentially,³¹ we specifically assessed the presence of several tRNAs in the rNef/eEF1A complexes in MDMs treated with rNef. MDMs treated with rNef were lysed and the presence of tRNAs in the immunoprecipitated eEF1A/rNef complexes was analyzed using RT-PCR. We detected the presence of all tested tRNAs, namely tRNAMet, tRNAPhe, tRNATrp, and tRNALys in the eEF1A/rNef complexes in MDMs (Figures 6a, c and d). Furthermore, the knockdown of eEF1A by siRNA resulted in the partial inhibition of tRNA binding to cytochrome c (Figure 6b). The ΔΔCt values were determined separately for untreated cells and averaged around 1 (Supplementary Figure 2).

The binding of tRNAs to cytochrome c was recently reported to inhibit caspase-9 activation. Therefore, we hypothesized that the enhanced nuclear–cytoplasmic transport of eEF1A/rNef/tRNA complexes mediated by Exp-t might result in higher levels of cytosolic tRNAs, which could target cytochrome c released in BFA-treated MDMs. Cytoplasmic extracts of MDMs treated with increasing amounts of rNef were tested for the presence of tRNAs complexed with immunoprecipitated eEF1A and cytochrome c. We observed that tRNA binds to eEF1A in the cytosol of BFA-treated MDMs in a Nef-dependent manner (Figure 6e). Similar results were obtained for the binding of tRNA to cytochrome c (Figure 6f), indicating that Nef treatment of BFA-stimulated MDMs favors the formation of tRNA/cytochrome c complexes in the cytoplasm. Cytoplasmic extracts of BFA-stimulated MDMs treated with rNef, in the absence or presence of Exp-t siRNA, Exp-1 siRNA, or Exp-5 siRNA, were analyzed for the presence of tRNA binding cytochrome c. Knockdown of Exp-t, but not Exp-1 or Exp-5, decreased the amount of tRNAs that bound to cytochrome c, as well as eEF1A, in BFA-stimulated MDMs treated with Nef (Figures 6g and h). Similarly, the knockdown of eEF1A by siRNA decreased the amount of tRNAs that were associated with cytochrome c in BFA-stimulated MDMs treated with Nef (Figure 6i).

Discussion

We observed a direct interaction between HIV-1 Nef and eEF1A. In rNef-treated MDMs, the rNef-mediated nuclear–cytoplasmic relocalization of eEF1A was dependent on Exp-t. We also report the specific presence of tRNAs in the rNef/eEF1A complexes. Nuclear–cytoplasmic relocalization of rNef/eEF1A/tRNA prevented stress-induced apoptosis of MDMs treated with BFA through decreased release of mitochondrial cytochrome c, enhanced tRNA binding to release cytosolic cytochrome c, and increased cytoplasmic levels of eEF1A, ultimately resulting in decreased caspase activation (Figure 7). Our results indicate that the HIV-1 Nef protein enhances resistance to stress-induced apoptosis in MDMs through the nuclear–cytoplasmic relocalization of rNef/eEF1A/tRNA complexes.

Our results show that nuclear–cytoplasmic transport of eEF1A/Exp-t/tRNA complexes occurs in MDMs treated with rNef. Although the role of eEF1A in tRNA transport has been reported, this is the first time that a viral protein such as Nef has been shown to be actively involved in such a process. The presence of relatively more amounts of eEF1A in the nucleus of MDMs confirms previous results indicating that eEF1A is localized in both the cytoplasm and nucleus of cells. We also observed that the nuclear–cytoplasmic distribution of eEF1A/rNef complexes included the presence of RNA (Figures 6a–d). Both proteins most probably bind to each other in an RNA-independent manner. First, we observed the interaction between Nef and eEF1A in a purified system (Figure 2a). Second, supportive experimental evidence comes from crosslinking studies between rabbit EF-1α GTP and aminoacyl-tRNA that indicate contact sites corresponding to residues 270–275, 345–355 and 375, sites that are in contact with the RNA in the ternary complex crystal.³² Finally, the N-terminal Arg-rich region of HIV-1 Nef (aa 1–22) binds to RNA in vitro.³¹ As the Nef fragment encoding amino acids 55–206 is sufficient for binding to the N-terminal extremity of eEF1A (Figure 2b), it is highly unlikely that the Nef interaction with eEF1A requires the presence of RNA.

We hypothesized that tRNA is the most likely candidate to be present in the Nef–eEF1A complex because eEF1A binds to aminoacyl-tRNA during translation and Nef has been shown to bind to tRNAs and promote the annealing of primer tRNA to viral genomic RNA. In addition, Exp-t, rather than Exp-5, has a critical role in this process, which is in agreement with a critical role of Exp-t in the selection and transport of mature tRNAs from the nucleus to the cytoplasm.

Nef has been reported to prevent both Fas and TNF receptor-mediated deaths in HIV-infected T cells via interaction with ASK-1, thereby blocking the extrinsic apoptosis pathway. Nef inhibits ASK-1, caspase-3, and caspase-8 activation, resulting in the blockade of apoptosis in HIV-infected cells. Nef has also been shown to block the intrinsic apoptosis pathway via inhibition of the pro-apoptotic protein Bad.³³ Our data highlight a new molecular mechanism elicited by the HIV-1 Nef protein to block the intrinsic apoptosis pathway in Nef-expressing cells, such as HIV-1-infected MDMs. The HIV-1 Nef protein, through the nuclear–cytoplasmic relocalization of rNef/eEF1A/tRNA complexes, could participate in preventing stress-mediated effects at several levels. First, the decreased cytochrome c release is probably due to cytoplasmic accumulation of eEF1A that stabilizes actin filaments and potentially could block the BFA-induced disruption of the organization of the microtubule and actin cytoskeleton. Second, the tRNAs could be specifically delivered by the eEF1A/Nef/tRNA complexes to cytosolic cytochrome c, thereby preventing cytochrome c interaction with Apaf-1 and blocking caspase activation and apoptosis. Third, the eEF1A protein could be delivered by the eEF1A/Nef/tRNA complexes in the cytoplasm to participate in cytoskeleton rearrangement aimed to eliminate unfolded proteins produced during stress events.^{34, 35, 36} Finally, eEF1A has been reported to activate Akt, the protein kinase B reported by numerous studies to favor resistance to apoptosis.¹¹ In order to determine the scope of eEF1A-mediated protection, we assayed eEF1A antiapoptotic activity in response to ER stress agents, BFA, TM and TG. BFA reversibly blocks protein transport between the ER and Golgi, whereas TM blocks the synthesis of all N-linked glycoproteins (N-glycans)³⁷ and TG inhibits the ER Ca2+-ATPase family of calcium pumps.³⁸ Our results indicate that Nef specifically blocks apoptosis induced by the ER-stress agent BFA, indicating that increased cytoplasmic relocalization of eEF1A by HIV-1 Nef may alleviate the inhibition of protein transport between the ER and Golgi observed in BFA-treated cells. In addition, Nef could favor an homeostatic control of UPR and of oxidative stress observed during the acute phase of HIV infection and subsequently fuel the progression of the disease toward a chronic infection with the formation of cellular reservoirs of the virus.

Taken together, the results indicate that cytoplasmic relocalization of the eEF1A/tRNAs complexes by HIV-1 Nef could ultimately favor the survival of the cell under stress, thereby allowing optimal viral replication. This event may participate in the formation and maintenance of viral reservoirs in HIV-infected persons.

Materials and Methods

Cell culture

Primary human MDMs were prepared from the peripheral blood of healthy donors and cultured in RPMI medium supplemented with 10% (v/v) pooled AB human serum (Sigma, Munich, Germany), as described previously.³⁹ PBLs were cultivated in RPMI medium supplemented with 10% (v/v) fetal bovine serum (FBS). Vero cells, MRC5 cells, and promonocytic U937 cells were obtained from the American Tissue Cell Culture Collection (ATCC, Manassas, VA, USA). The cell lines were cultivated in RPMI 1640 supplemented with 10% FBS, 1% glutamine, and 1% penicillin/streptomycin.

Recombinant Nef treatment

MDMs (5 × 10⁶ cells) were treated with recombinant myristoylated Nef protein (rNef) from Jena Bioscience (Jena, Germany). Cell pellets were collected at various times after treatment, washed extensively, and either lysed for western blot analysis or fixed with 3% paraformaldehyde in PBS for 30 min for the TUNEL assay in flow cytometric analysis. The bacterially expressed GST-Nef(WT), GST-Nef(1-60) and GST-Nef(55-206) were purified and cleaved with thrombin (cat# 27-0846-01 GE Healthcare Ltd., Little Chalfont, UK) according to the instruction provided by the manufacturer. SDS-tricine polyacrylamide gel electrophoresis (PAGE) and coomassie staining was done to visualize the thrombin cleaved products of HIV-1Nef wild type and mutants.

Isolation of nuclear and cytoplasmic extracts

Nuclear and cytoplasmic extracts were isolated as described previously.³⁹ Cells were scraped from the plastic surface of the culture dishes and washed with wash buffer (10 mM HEPES pH 7.6, 10 mM KCl, 2 mM MgCl2, 1 mM EDTA). Cell pellets were incubated on ice with cytoplasmic isolation buffer (10 mM HEPES pH 7.6, 10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 0.02% Nonidet P-40). Supernatants containing cytoplasmic extracts were collected by centrifugation leaving the nuclear pellets. The pellets were washed twice in wash buffer, spun, and incubated for 15 min on ice with nuclear isolation buffer (20 mM HEPES pH 7.6, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25% glycerol). Supernatants containing nuclear extracts were collected by centrifugation and stored at −80 °C. Protease inhibitors (1 mM DTT, 1 mM PMSF, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin) were added to all solutions. Protein concentrations in the nuclear and cytoplasmic extracts were determined by the Bradford method using a BioPhotometer (Eppendorf, Hamburg, Germany).

Preparation of cytosolic and mitochondrial fractions

Cytosolic and mitochondrial fractions were prepared using the cell fractionation kit-standard (#MS861, Mitosciences, Eugene, OR, USA). The coxIV (Cell Signaling Technology, Danvers, MA, USA) antibody was used as a mitochondrial loading control.

Immunoprecipitation

Vero cells, MRC5 cells, U937 cells, PBLs, or primary MDMs were left untreated or treated with rNef for different periods of time. Cell lysates were precleared by adding 50 μl of Protein G Plus/Protein A-Agarose (Calbiochem-Novabiochem, Bad Soden, Germany) for 1 h at 4 °C. The cleared supernatants were removed, combined with 5 μg anti-Nef or anti-EF1A antibodies (Chemicon, Upstate, Billerica, MA, USA), and incubated overnight at 4 °C. Immune complexes were washed in the presence of protease inhibitors, the bound proteins eluted with sample buffer, and the proteins run on a 10% SDS-PAGE gel. SDS-PAGE and western blot analysis were performed according to standard procedures. Beta-actin and TATA-binding protein (TBP) (Sigma, St. Louis, MO, USA) were used as cytoplasmic or nuclear loading controls, respectively. Western blots were developed using the ECL detection kit (Amersham Pharmacia Biotech, Little Chalfont, UK).

Plasmids and construction of expression vectors

Deletion constructs were generated by standard PCR and cloning procedures.⁴⁰ HIV-1 Nef constructs were verified by DNA sequencing. eEF1A/Nef interactions were detected in vivo by transient co-transfection of GAL4-Nef and VP16-eEF1A in the context of a mammalian two-hybrid system (CheckMate, Promega, Madison, WI, USA). Sequence authenticity was confirmed by DNA cycle sequencing. HIV-1 Nef wild type, N-terminus (1-60), or C-terminus (55–206) was cloned into pGEX-4T-1 expression vector. For protein purification purposes, each construct was transformed into bacteria (BL21DE from Novagen, Madison, WI, USA). A single colony was inoculated in 5 ml LB broth plus 50 μg/ml ampicillin at 37 °C in a shaker overnight. A 1-ml aliquot of the overnight bacterial culture was used to inoculate 300 ml LB broth plus 50 μg/ml ampicillin and grown for 2.5 h at 37 °C in a shaker (until OD600=0.5). IPTG was added at a final concentration of 0.1 mM and the culture grown for an additional 3 h at 37 °C in the shaker. Bacteria were pelleted, washed with ice-cold TBS, and lysed in bacterial protein extraction reagents (Pierce, Rockford, IL, USA). eEF1A and mutants (kindly provided by Dr. A Cimarelli, ENS-L, Lyon, France) were constructed and expressed in the bacteria, as described previously.²⁴

Transfection assay

To carry out transient transfections, the DNA concentration was kept constant in the different samples by using the corresponding empty vector. A total of 5 × 10⁶ cells were transfected with 5–10 μg total plasmid DNA, which included the firefly luciferase-expressing vector using the DEAE-dextran procedure. Luciferase activity in cell lysates was measured 48 h post transfection using a luminometer (TD-20/20, Promega). Luciferase expression was normalized with respect to protein concentration using the Detergent-Compatible Protein Assay (Bio-Rad, Munich, Germany). All transfections were performed in triplicate.

Pull-down assays

Fragments of the cDNA encoding HIV-189.6 Nef were produced using convenient restriction enzymes and PCR methods and then cloned into the glutathione S transferase (GST) fusion vector pGEX-4T-1 (Amersham Biosciences, Little Chalfont, UK). The GST constructs (Nef[1-60] and Nef[55-206]) kindly provided by Dr. Fackler (University of Heidelberg, Germany) were transformed into the E. coli strain BL21 (Stratagene, La Jolla, CA, USA), and the GST fusion proteins were purified according to the manufacturer’s instructions. For pull-down assays, 20 μg of the GST–Nef proteins (NefWT, Nef[1–60], Nef[55–206]) were incubated overnight at 4 °C with 1500 μg of MDM lysates. The suspension was then washed three times in PBS, denaturized, and subsequently separated by SDS-PAGE before autoradiography.

RNA interference

MDM cultures (0.5 × 10⁶ cells) were transfected with a scrambled control, Exp-t siRNA, Exp-1 siRNA, Exp-5 siRNA duplex (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or eEF1A siRNA (Dharmacon, Lafayette, CO, USA) using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA). MDMs were treated with rNef 48 h post transfection, and eEF1A, rNef, Exp-t, Exp-1, and Exp-5 protein expression and MDM apoptosis were analyzed by western blot and the annexin-V (Invitrogen) assay, respectively. Transfection efficiency was monitored using a fluorescein-conjugated scrambled control duplex, exceeding 80% in MDMs.

tRNA interaction with cytochrome c, eEF1A, or Nef

To examine the tRNA/cytochrome c interaction in vivo, MDMs transfected with Exp-t siRNA, Exp-1 siRNA, Exp-5 siRNA, eEF1A siRNA or scramble siRNA for 48 h before treatment with rNef were harvested and washed twice with ice-cold PBS. The cytoplasmic extracts were immunoprecipitated with anti-cytochrome c antibody (Santa Cruz Biotechnology) at 4 °C overnight followed by incubation with protein G agarose beads for an additional 2 h. The beads were washed and resuspended in 200 μl RNA elusion buffer (50 mM Tris, 100 mM NaCl, 10 mM EDTA, 0.1% SDS) at 65 °C for 10 min. RNA was extracted (RNeasy kit, Qiagen, Valencia, CA, USA) and cDNA synthesized using a cDNA synthesis kit (Invitrogen).

The sequence of the primers (Eurogentec, Seraing, Belgium) used in RT-PCR amplification were as follows:

tRNAMet forward 5′-CTGGGCCCATAACCCAGAG-3′

tRNAMet reverse 5′-TAGCAGAGGATGGTTTCGAT-3′

tRNATrp forward 5′-GGCTCGTTGGTCTAGGGGTA-3′

tRNATrp reverse 5′-GATTTGAACCCGGGACCT-3′

tRNAPhe forward 5′-CCTCCTCAAAGCAATACACTGA-3′

tRNAPhe reverse 5′-GGTGATGTGAGCCCGTCTAA-3′

tRNALys forward 5′-ATAGCTCAGTCGGTAGAGCATCA-3′

tRNALys reverse 5′-ACAGGGACTTGAACCCTGGAC-3′

The tRNAs associated with eEF1A, rNef and cytochrome c were detected after immunoprecipitation with an anti-eEF1A and anti-cytochrome c or anti-Nef antibody, followed by RT-PCR amplification as described above. Ct values were analyzed using the ΔΔCt method.⁴¹ ΔCt was calculated by normalization to the isotype control, and ΔΔCt values were calculated by normalizing to the Ct values of the untreated sample. The ΔΔCt values were also determined separately for untreated cells and averaged around 1 (Supplementary Figure 2).

Detection of apoptosis

The detection of apoptosis by the annexin-V–propidium iodide assay (Invitrogen) and TUNEL assay (AbD Serotec, Oxford, UK) was performed as previously described.²⁸ For ER stress agents, an appropriate dose was selected from a range of concentrations tested. BFA (Sigma), TG (Sigma) and TM (Sigma) were used at 10 μg/ml.

Caspase activity

Caspase-9 and caspase-3 activity was measured by western blotting as described previously.³⁰ Where specified, protein levels were quantified by densitometry using ImageJ 1.40 software (National Institutes of Health, Bethesda, MA, USA).

Statistical analysis

Statistical analyses were performed using the analysis of variance (ANOVA) test, and differences were considered significant at a value of *P<0.05, **P<0.01, ***P<0.001. Microsoft Excel was used to construct the plots.

Abbreviations

Ab:: antibody
AIDS:: acquired immune deficiency syndrome
ANOVA:: analysis of variance
Apaf-1:: apoptotic peptidase-activating factor-1
ASK-1:: apoptosis signal-regulating kinase 1
BFA:: brefeldin A
DTT:: dithiothreitol
EF1A:: translation elongation factor 1 alpha
EF1β:: elongation factor 1 beta
eEF2:: eukaryotic translation elongation factor-2
ER:: endoplasmic reticulum
EtBr:: ethidium bromide
Exp-t:: exportin-t
Exp-1:: exportin-1
Exp-5:: exportin-5
FBS:: fetal bovine serum
GST:: glutathione S transferase
HIV:: human immunodeficiency virus
IPTG:: isopropyl β-D-1-thiogalactopyranoside
LMB:: leptomycin B
MDMs:: monocyte-derived macrophages
MHC-I:: major histocompatibility complex class I
PAGE:: polyacrylamide gel electrophoresis
PAK:: p21-activated kinase
PBLs:: peripheral blood lymphocytes
PBMCs:: peripheral blood mononuclear cells
PI3K:: phosphatidylinositol-3 kinase
PMSF:: phenylmethylsulfonyl fluoride
ROS:: reactive oxygen species
rNef:: recombinant Nef
RT-PCR:: reverse transcription polymerase chain reaction
TBP:: TATA-binding protein
TG:: thapsigargin
TM:: tunicamycin
TNF:: tumor necrosis factor
TRX:: thioredoxin
TUNEL:: terminal deoxynucleotidyl transferase dUTP nick end labeling
UPR:: unfolded protein response
WT:: wild type

References

Walter P, Ron D . The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334: 1081–1086.
Article CAS PubMed Google Scholar
Shore GC, Papa FR, Oakes SA . Signaling cell death from the endoplasmic reticulum stress response. Curr Opin Cell Biol 2011; 23: 143–149.
Article CAS PubMed Google Scholar
Elbim C, Pillet S, Prevost MH, Preira A, Girard PM, Rogine N et al. Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J Virol 1999; 73: 4561–4566.
CAS PubMed PubMed Central Google Scholar
Masutani H, Ueda S, Yodoi J . The thioredoxin system in retroviral infection and apoptosis. Cell Death Diff 2005; 12: 991–998.
Article CAS Google Scholar
Uhm HD, Orenstein JM, Wahl SM . Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 1996; 156: 3469–3477.
Google Scholar
Aillet F, Masutani H, Elbim C, Raoul H, Chene L, Nugeyre MT et al. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4+ T- or monocytic cell lines. J Virol 1998; 72: 9698–9705.
CAS PubMed PubMed Central Google Scholar
Tiedde LM, Cook EA, Morsey B, Fox HS . Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins. Cell Death Dis 2011; 2: e246.
Article Google Scholar
Kohler A, Hurt E . Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol Cell Biol 2007; 8: 761–773.
Article PubMed Google Scholar
Calado A, Treichel N, Muller EC, Otto A, Kutay U . Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA. EMBO J 2002; 21: 6216–6224.
Article CAS PubMed PubMed Central Google Scholar
Liu G, Grant WM, Persky D, Latham Jr VM, Singer RH, Condeelis J . Interactions of elongation factor 1 alpha with F-actin and beta-actin mRNA: implications for anchoring mRNA in cell protrusions. Mol Biol Cell 2002; 13: 579–592.
Article CAS PubMed PubMed Central Google Scholar
Amiri A, Noei F, Jeganathan S, Kulkarni G, Pinke DE, Lee JM . eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 2007; 26: 3027–3040.
Article CAS PubMed Google Scholar
Murray JW, Edmonds BT, Liu G, Condeelis J . Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends. J Cell Biol 1996; 135: 1309–1321.
Article CAS PubMed Google Scholar
Duttaroy A, Bourbeau D, Wang XL, Wang E . Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp Cell Res 1998; 238: 168–176.
Article CAS PubMed Google Scholar
Lamberti A, Longo O, Marra M, Tagliaferri P, Bismuto E, Fiengo A et al. C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A. Cell Death Differ 2007; 14: 952–962.
Article CAS PubMed Google Scholar
Mateyak MK, Kinzy TG . eEF1A: thinking outside the ribosome. J Biol Chem 2010; 285: 21209–21213.
Article CAS PubMed PubMed Central Google Scholar
Foster JL, Garcia JV . HIV-1 Nef: at the crossroads. Retrovirology 2008; 5: 84.
Article PubMed PubMed Central Google Scholar
Ross TM, Oran AE, Cullen BR . Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 1999; 9: 613–621.
Article CAS PubMed Google Scholar
Kirchhoff F . Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010; 8: 55–67.
Article CAS PubMed Google Scholar
Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D . HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391: 397–401.
Article CAS PubMed Google Scholar
Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC . HIV-1 Nef inhibits ASK1- dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 2001; 410: 834–838.
Article CAS PubMed Google Scholar
Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 2001; 7: 1217–1224.
Article CAS PubMed Google Scholar
Olivetta E, Federico M . HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis. Exp Cell Res 2006; 312: 890–900.
Article CAS PubMed Google Scholar
Herbein G, Gras G, Khan KA, Abbas W . Macrophage signaling in HIV-1 infection. Retrovirology 2010; 7: 34.
Article PubMed PubMed Central Google Scholar
Cimarelli A, Luban J . Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol 1999; 73: 5388–5401.
CAS PubMed PubMed Central Google Scholar
Alessandrini L, Santarcangelo AC, Olivetta E, Ferrantelli F, d'Aloja P, Pugliese K et al. T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS. J Gen Virol 2000; 81: 2905–2917.
Article CAS PubMed Google Scholar
Li J, Yuan J . Caspases in apoptosis and beyond. Oncogene 2008; 27: 6194–6206.
Article CAS PubMed Google Scholar
Guo H, Tittle TV, Allen H, Maziarz RT . Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp Cell Res 1998; 245: 57–68.
Article CAS PubMed Google Scholar
Talapatra S, Wagner JD, Thompson CB . Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis. Cell Death Diff 2002; 9: 856–861.
Article CAS Google Scholar
Kobayashi Y, Yonehara S . Novel cell death by downregulation of eEF1A1 expression in tetraploids. Cell Death Diff 2009; 16: 139–150.
Article CAS Google Scholar
Mei Y, Yong J, Liu H, Shi Y, Meinkoth J, Dreyfuss G et al. tRNA binds to cytochrome c and inhibits caspase activation. Mol Cell 2010; 37: 668–678.
Article CAS PubMed PubMed Central Google Scholar
Echarri A, Gonzalez ME, Carrasco L . The N-terminal Arg-rich region of human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef is involved in RNA binding. Eur J Biochem 1997; 246: 38–44.
Article CAS PubMed Google Scholar
Nissen P, Kjeldgaard M, Thirup S, Polekhina G, Reshetnikova L, Clark BF et al. Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog. Science 1995; 270: 1464–1472.
Article CAS PubMed Google Scholar
Fackler OT, Baur AS . Live and let die: Nef functions beyond HIV replication. Immunity 2002; 16: 493–497.
Article CAS PubMed Google Scholar
Chuang SM, Chen L, Lambertson D, Anand M, Kinzy TG, Madura K . Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol 2005; 25: 403–413.
Article CAS PubMed PubMed Central Google Scholar
Hotokezaka Y, Tobben U, Hotokezaka H, Van Leyen K, Beatrix B, Smith DH et al. Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides. J Biol Chem 2002; 277: 18545–18551.
Article CAS PubMed Google Scholar
Nicchitta CV . Cell biology: how to combat stress. Nature 2009; 457: 668–669.
Article CAS PubMed Google Scholar
Resh MD . Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods 2006; 40: 191–197.
Article CAS PubMed PubMed Central Google Scholar
Michelangeli F, East JM . A diversity of SERCA Ca2+ pump inhibitors. Biochem Soc Trans 2011; 39: 789–797.
Article CAS PubMed Google Scholar
Varin A, Manna SK, Quivy V, Decrion AZ, Van Lint C, Herbein G et al. Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. J Biol Chem 2003; 278: 2219–2227.
Article CAS PubMed Google Scholar
Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E . Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci USA 1998; 95: 2795–2800.
Article CAS PubMed PubMed Central Google Scholar
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Article CAS PubMed Google Scholar

Download references

Acknowledgements

This work was supported by grants from the University of Franche-Comté (UFC) to GH. OR is supported by grants from University of Strasbourg, Agence Nationale de la Recherche sur le SIDA (ANRS), Ligue Nationale de Recherche contre le Cancer and Institut Universitaire de France (IUF). WA and KAK are recipients of doctoral scholarships from the Higher Education Commission, Pakistan. AK is a recipient of a postdoctoral fellowship of the Région Franche-Comté (no. 2012C-06102).

Author information

Authors and Affiliations

Department of Virology, Pathogens & Inflammation Laboratory, University of Franche-Comte, EA 4266, SFR FED 4234, CHRU Besancon, Besançon, F-25030, France
W Abbas, K A Khan, A Kumar, M K Tripathy, I Dichamp, M Keita & G Herbein
University of Heidelberg Medical Center, St. Lukas Klinik Solingen, Solingen, D-42697, Germany
U Mahlknecht
Institut de Parasitologie et Pathologie Tropicale, EA 4438, Strasbourg University, 3 rue Koeberlé, Strasbourg, 67000, France
O Rohr

Authors

W Abbas
View author publications
You can also search for this author in PubMed Google Scholar
K A Khan
View author publications
You can also search for this author in PubMed Google Scholar
A Kumar
View author publications
You can also search for this author in PubMed Google Scholar
M K Tripathy
View author publications
You can also search for this author in PubMed Google Scholar
I Dichamp
View author publications
You can also search for this author in PubMed Google Scholar
M Keita
View author publications
You can also search for this author in PubMed Google Scholar
U Mahlknecht
View author publications
You can also search for this author in PubMed Google Scholar
O Rohr
View author publications
You can also search for this author in PubMed Google Scholar
G Herbein
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Herbein.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Edited by G Melino

Supplementary Information accompanies this paper on Cell Death and Disease website

Supplementary information

Supplementary Figures (PPT 173 kb)

Supplementary Figure Legends (DOC 28 kb)

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Abbas, W., Khan, K., Kumar, A. et al. Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein. Cell Death Dis 5, e1080 (2014). https://doi.org/10.1038/cddis.2014.16

Download citation

Received: 11 January 2013
Revised: 14 December 2013
Accepted: 08 January 2014
Published: 20 February 2014
Issue Date: February 2014
DOI: https://doi.org/10.1038/cddis.2014.16